Eating Disorders
38 articles on Eating Disorders, researched and written by the Shotlee Editorial Team from primary sources.
GLP-1s for Teen Weight Loss: A New Treatment Trend?
GLP-1 medications are rapidly changing obesity care for teens and young adults, with a notable shift away from bariatric surgery. This article delves into the latest research, potential benefits, and important considerations for this emerging trend.
7 min read
Plus-Size Swimsuit Model on Inclusivity Amidst GLP-1 Medications
Plus-size model Hunter McGrady shares her concerns about a perceived decline in fashion inclusivity, particularly in the context of the growing popularity of GLP-1 weight loss medications.
7 min read
Mounjaro's Impact on Food Cravings: A Case Study
A groundbreaking case study involving deep brain activity recordings has shed light on how tirzepatide, known as Mounjaro and Zepbound, impacts the brain's reward center and its connection to food cravings and loss of control eating.
8 min read
Ozempic & Wegovy Safety: The Yale Study on Online Prescribing
A recent JAMA study reveals significant gaps in medical oversight for online GLP-1 prescriptions. Discover the risks and how to ensure safe access to weight loss medications.
7 min read
GLP-1s and Menopause: Expert Warns of Accelerated Bone Loss Risk
The collision of rapid weight loss driven by GLP-1 medications like Wegovy and Mounjaro with the natural bone density decline of menopause creates a significant, under-discussed risk for women's skeletal health.
6 min read
Ozempic, Wegovy & Mounjaro: Weighing Risks for Young Patients on GLP-1s
As GLP-1 medications gain traction for weight management, doctors are increasingly prescribing them to adolescents. While short-term benefits are evident, significant questions remain about the long-term implications for young, developing bodies and minds.
7 min read
Alli Weight Loss Pill: FDA Flags Serious Kidney Risks
The Food and Drug Administration (FDA) has issued a new warning regarding potential serious kidney complications associated with Alli, the sole over-the-counter weight loss medication available in the United States. The drug's label has been updated to reflect these risks, urging caution for consumers.
8 min read
Alli's Kidney Risk: FDA Updates Label for Over-the-Counter Weight Loss Pill
The FDA has issued a critical update to the drug facts label for Alli, the only over-the-counter weight loss medication available in the U.S. The changes highlight rare but potentially severe kidney-related side effects, prompting new warnings for consumers.
7 min read
Beyond BMI: Hidden Health Reasons Doctors May Decline Mounjaro or Wegovy
While BMI is a primary factor, a range of underlying health conditions and personal histories can lead to a doctor declining a prescription for popular weight loss medications like Mounjaro and Wegovy. Understanding these criteria is vital before seeking treatment.
7 min read
Beyond BMI: Why Mounjaro Eligibility is More Complex Than You Think
Many assume BMI is the sole determinant for Mounjaro prescriptions, but the reality is far more nuanced. This article explores the comprehensive health criteria healthcare providers use to ensure safe and effective treatment.
6 min read
Ozempic, Wegovy & Mounjaro: AI Uncovers New Patient-Reported Side Effects
New research leverages AI to sift through vast online discussions, identifying patient-reported side effects of popular GLP-1 medications that may not be fully captured in clinical trials.
7 min read
GLP-1s & Eating Disorders: A Growing Concern for Patients and Doctors
The effectiveness of GLP-1 medications like Ozempic, Wegovy, and Mounjaro for weight loss has led to widespread adoption. However, a concerning trend is emerging: individuals with a history of or current eating disorders are increasingly turning to these drugs, raising alarm bells among healthcare professionals dedicated to eating disorder recovery.
9 min read
Ozempic, Mounjaro & More: AI Uncovers Hidden GLP-1 Side Effects
Popular GLP-1 medications such as semaglutide and tirzepatide are revolutionizing weight loss and diabetes management. A groundbreaking study using AI to analyze over 400,000 Reddit posts has shed light on potential side effects that may not be fully captured in traditional clinical trials, offering valuable insights for patients and healthcare providers.
7 min read
The 'Ozempic Personality': Understanding Emotional Changes with GLP-1s
While GLP-1 medications are celebrated for weight loss and reduced food noise, some users report emotional flattening. This article delves into the 'Ozempic personality' phenomenon, its potential causes, and expert perspectives on managing these psychological shifts.
7 min read
Is 'Ozempic Personality' Real? Mental Health Complaints Examined
Ozempic has transformed weight loss by silencing 'food noise' for many users, but now 'Ozempic personality' is sparking debate. A report highlights mental health complaints during treatment. Is this side effect real, or just hype?
5 min read
Untold Dangers of GLP-1s: Ozempic, Wegovy & Mounjaro Risks
Wegovy, Ozempic, and Mounjaro promise effortless weight loss with minimal risk, but new research uncovers deeper dangers like altered brain chemistry and loss of desire. On The Spectacle Podcast, Scott McKay and Melissa Mackenzie dive into the science, Melissa's personal story, and why lifestyle changes offer a safer path.
5 min read
How Layla Taylor Got GLP-1 in Utah: Eating Disorder Warning
Reality star Layla Taylor shares her concerning experience obtaining a GLP-1 prescription with alarming ease in Utah, revealing how the medication became an 'unhealthy crutch' amid her long-term battle with an eating disorder. Her story highlights critical gaps in patient screening and mental health considerations.
7 min read
Telangana Warns on Semaglutide Misuse for Weight Loss
Telangana's Drugs Control Administration has issued a stark warning against misusing Semaglutide formulations for weight loss without medical oversight. With patent expiry looming in March 2026, multiple versions are flooding the market, raising safety concerns. Improper use risks serious complications like pancreatitis and gastrointestinal disorders.
5 min read
Ozempic's Impact on Gay Men's Body Image and Bottoming
Ozempic and other GLP-1 medications promise weight loss and health gains, but they're fueling toxic body image problems in the gay community. Queer celebs like Margaret Cho and Boy George are praising the drugs, yet experts highlight risks to body confidence and even the ability to bottom. No studies yet focus on LGBTQ+ users, but the impacts are real.
5 min read
Why Layla Taylor Quit GLP-1s: Mormon Wives Star's Story
Layla Taylor, star of The Secret Lives of Mormon Wives, has stepped away from GLP-1 medications after using them as an unhealthy crutch for her lifelong eating disorder. Ahead of season 4, she opens up about hidden side effects like aching joints, falling hair, and constant fatigue that signaled her body was breaking down. Her story underscores the importance of monitoring GLP-1 use, especially with pre-existing conditions.
6 min read
Beyond the Scale: GLP-1 Medications' Impact on Body and Mind
Alexis Ioane hesitated before starting tirzepatide, a GLP-1 medication, but two months in, she's shed pounds, gained energy for her kids, and cleared her mind. While GLP-1s like Ozempic and Wegovy promise transformative weight loss, experts caution about mental health effects. Discover the full story on body and mind impacts.
6 min read
Why Silencing Food Noise Requires More Than Ozempic
Food noise isn't just hunger—it's exhausting mental commentary on dieting, body image, and worthiness shaped by culture. While Ozempic and GLP-1 agonists like Wegovy promise relief, clinicians Bronwyn Wood and Courtney Nelson argue for a broader approach. Their workshops challenge weight-centric care to foster true silencing through body neutrality and informed prescribing.
6 min read
Intermittent Fasting No Better for Weight Loss Than Dieting, Cochrane Review ...
New Cochrane research reveals intermittent fasting offers no weight loss advantage over traditional dietary advice or even no intervention at all. Analyzing 22 studies with 1,995 overweight or obese adults, the review highlights similar outcomes across groups. Discover the details and potential benefits beyond the scale.
5 min read
Netflix Docuseries Doesn't Let Tyra Banks Off Easy on ANTM
Tyra Banks faces scrutiny in Netflix's candid docuseries on America's Next Top Model, revealing body shaming, production mishandling of assaults, and her conflicting ideals. From blackface controversies to pressuring contestants on appearance, the three-part series gives voice to models and judges. It's a raw look at reality TV's dark side and the limits of progress in body positivity.
4 min read
How GLP-1 Drugs May Lead to New Eating Disorders
As millions use GLP-1 medications like Ozempic for weight loss, clinicians are seeing a rise in new eating disorders dubbed 'agonorexia.' These drugs' powerful appetite suppression may drive dangerous food and body image obsessions, even in those without prior history. Experts warn current screening may miss at-risk patients.
6 min read
GLP-1 Obesity Drugs Complicate Life for People with Disordered Eating
Jason Krynicki, once bullied for obesity, now battles anorexia while on Zepbound, fearing weight regain if he stops. GLP-1 drugs curb appetite effectively but complicate lives for those with disordered eating, often without proper screening. Experts highlight risks and call for caution in a weight-stigma culture.
5 min read
GLP-1 Drugs & Fertility: Surprising Pregnancies on Mounjaro, Ozempic
Women on GLP-1 drugs like tirzepatide and semaglutide are reporting surprise pregnancies after significant weight loss. This guide explains the mechanisms, emerging trends, and essential precautions for those on these medications considering family planning.
5 min read
GLP-1 Drugs and Eating Disorders: Risks of Telehealth Prescribing
A woman's relapse into an eating disorder after online prescription of GLP-1 drugs highlights growing concerns about telehealth practices. Experts from the Royal College of GPs warn of safety gaps, urging caution with these powerful medications. Discover the science, risks, and best practices for safe use.
4 min read
GLP-1 Drugs for Obesity: Why Treatment is Lifelong Like Oprah's Story
Oprah Winfrey shared on her podcast that stopping GLP-1 injections led to significant weight regain, sparking debate on obesity treatment. Expert insights reveal these drugs treat a chronic condition, not just temporary weight loss. Learn the science, risks, and how to approach long-term success.
4 min read
Saccharine: Horror Lessons on GLP-1 Weight Loss Realities
The chilling film 'Saccharine' imagines a diet pill worse than Ozempic—made from human ashes. But what does it reveal about real GLP-1 weight loss drugs? This guide dives into the science, psychological pitfalls, and evidence-based tips for safe use.
4 min read
GLP-1 Revolution: Ozempic, Wegovy, Mounjaro Rise
GLP-1 injections like Ozempic, Wegovy, and Mounjaro have exploded from niche diabetes therapies to cultural icons in weight management. While offering profound metabolic benefits, their rapid mainstreaming raises questions about proper use, side effects, and societal pressures. This guide unpacks the science, real-world stories, and future implications.
4 min read
Ozempic Reshaping Beauty Standards Toward Thinness
Ozempic, originally for diabetes, has sparked a cultural shift toward extreme thinness as the new beauty ideal. This rapid reversal from body positivity creates intense social pressures and physical risks like muscle loss. Understand the implications for body image and long-term health.
2 min read
Monster of 2025: GLP-1 Promotions
The year 2025 has seen a relentless barrage of ads promoting GLP-1 medications for weight loss, often bypassing FDA approvals and focusing on cosmetic benefits. Despite regulations limiting their use to specific medical conditions, telehealth companies push compounded versions aggressively. This trend threatens to undermine the body positivity movement by exploiting insecurities for profit.
5 min read
Rising Concerns Over Telehealth Weight Loss Programs
Health experts are expressing significant alarms over the promotion of virtual weight loss initiatives to those in fragile states. Advocacy organizations highlight indirect drug recommendations lacking adequate safeguards. Telehealth providers defend their practices while critics push for better regulation.
3 min read
Black Friday Promotion of Weight-Loss Drugs Sparks Worries
Experts in eating disorders express alarm over the swift introduction of GLP-1 weight-loss drugs through telehealth platforms and intense social media promotions by certain firms. One instance highlighted references to restrictive Australian regulations hindering detailed medication info for buyers. The Australia and New Zealand Academy for Eating Disorders fears such tactics might appeal to those who don't require the drugs.
5 min read
Creator Claims Pro-ED Culture Is Back Amid Hollywood's Ozempic Craze in Viral Video
A TikTok creator's video, viewed over 6 million times, criticizes the increasing prevalence of extreme thinness among celebrities and its potential impact on viewers. The creator expresses frustration with what she sees as an unhealthy trend being normalized and even praised.
3 min read
Fresh Insights into Mounjaro for Weight Loss Could Improve Impulsive Eating Treatments
Recent research from the University of Pennsylvania indicates that tirzepatide, known as Mounjaro and Zepbound, may lessen brain signals linked to persistent food cravings. The study suggests potential advancements in treating conditions like binge eating disorder by targeting the neurological roots of 'food noise'.
3 min read
GLP-1 Weight Loss & Body Image: Navigating the Complexities of Health & Criticism
This post dives into the complexities of GLP-1 medications, body image, and navigating criticism in your health journey, offering actionable tips for wellness.
3 min read